AstraZeneca PLC

AZN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/30/2025
12/31/2024
Assets
Cash & Equivalents$8,143,000$7,058,000$5,230,000$5,488,000
Short-Term Investments$39,000$50,000$165,000$166,000
Receivables$14,338,000$14,168,000$13,250,000$12,972,000
Inventory$6,593,000$6,467,000$5,884,000$5,288,000
Other Curr. Assets$827,000$1,196,000$1,610,000$1,913,000
Total Curr. Assets$29,940,000$28,939,000$26,139,000$25,827,000
Property Plant & Equip (Net)$13,783,000$13,229,000$12,303,000$11,647,000
Goodwill$21,219,000$21,222,000$21,130,000$21,025,000
Intangibles$38,191,000$37,925,000$37,550,000$37,177,000
Long-Term Investments$2,286,000$4,851,000$1,900,000$1,734,000
Tax Assets$0$6,256,000$6,095,000$5,347,000
Other NC Assets$9,037,000$0$1,136,000$1,278,000
Total NC Assets$84,516,000$83,483,000$80,114,000$78,208,000
Other Assets$0$0$0$0
Total Assets$114,456,000$112,422,000$106,253,000$104,035,000
Liabilities
Payables$25,028,000$23,986,000$22,544,000$22,465,000
Short-Term Debt$6,203,000$6,492,000$3,425,000$2,156,000
Tax Payable$0$1,429,000$0$1,406,000
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,444,000$1,268,000$2,805,000$1,500,000
Total Curr. Liab.$34,054,000$33,536,000$29,129,000$27,866,000
LT Debt$24,700,000$24,714,000$26,741,000$26,506,000
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$3,615,000$0$3,305,000
Other NC Liab.$8,352,000$4,475,000$8,056,000$4,374,000
Total NC Liab.$34,431,000$34,076,000$35,993,000$35,298,000
Other Liabilities$0$0$0$0
Cap. Leases$1,758,000$1,633,000$1,551,000$1,452,000
Total Liabilities$68,485,000$67,612,000$65,122,000$63,164,000
Equity
Pref Stock$0$0$0$0
Common Stock$388,000$388,000$388,000$388,000
Retained Earnings$8,213,000$7,023,000$3,364,000$3,160,000
AOCI$2,044,000$2,070,000$2,054,000$0
Other Equity$0$0$0$2,012,000
Total Equity$45,888,000$44,719,000$41,039,000$40,786,000
Supplemental Information
Minority Interest$83,000$91,000$92,000$85,000
Total Liab. & Tot. Equity$114,456,000$112,422,000$106,253,000$104,035,000
Net Debt$22,760,000$24,148,000$24,936,000$23,174,000